Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Doxorubicin (50 mg dosage formulation) is a potent, red-colored cytotoxic chemotherapy agent often branded as Adriamycin. It belongs to the anthracycline class, commonly used in treating a wide range of solid tumors and hematological malignancies, including breast cancer, lymphomas, and sarcomas.
| Strength | 50 mg / 25 mL (2mg/ml ) |
| Container | Single-dose vial |
| Administration | Intravenous injection (usually 2 mg/mL concentration) |
| Form | Liquid injection, Lyophilized (powder) for injection |
| Main Ingredients | Doxorubicin Hydrochloride Injection |